
CannaPharmaRx Inc
OTC:CPMD

Gross Margin
CannaPharmaRx Inc
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | Company | Market Cap |
Gross Margin |
||
---|---|---|---|---|---|
CA |
![]() |
CannaPharmaRx Inc
OTC:CPMD
|
2.6m USD |
-235%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
729.1B USD |
82%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
56%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
364B USD |
68%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK |
84%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
207.2B CHF |
74%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF |
76%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
161.6B GBP |
82%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
201.7B USD |
78%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD |
68%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
136.6B USD |
75%
|
CannaPharmaRx Inc
Glance View
CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on CannaPharmaRx Inc's most recent financial statements, the company has Gross Margin of -234.8%.